摘要
急性缺血性脑卒中(AIS)患者因大脑内动脉突然闭塞,阻断了供应大脑的血液,临床上多出现一侧面部麻木或嘴角歪斜、一侧肢体无力或麻木、言语笨拙或语言理解障碍等症状。如果治疗出现延迟,脑组织缺血时间将会延长并出现不可逆的坏死,神经系统功能可能会永久缺损。近年来世界各国在静脉溶栓治疗研究方面取得了较大的进展,本研究对急性缺血性脑卒中患者静脉溶栓治疗的年龄、药物、剂量、时间窗及溶栓效果的影响因素进行综述。
Acute ischemic stroke(AIS)patients have a sudden occlusion of the internal cerebral artery,blocking the blood supply to the brain.Clinically,they often have facial numbness or crooked mouth,weakness or numbness of one limb,clumsy speech or language comprehension disorder and other symptoms.If the treatment is delayed,the ischemic time of the brain tissue will be prolonged and irreversible necrosis will occur,and the nervous system function may be permanently impaired.In recent years,countries around the world have made great progress in the research of intravenous thrombolytic therapy.This study summarizes the influencing factors of age,drugs,dose,time window and thrombolytic effect of intravenous thrombolytic therapy in patients with acute ischemic stroke.
作者
宋贵军
SONG Gui-jun(Department of Neurology,Tianjin Ninghe District Hospital,Tianjin 301500,China)
出处
《医学信息》
2020年第17期47-49,53,共4页
Journal of Medical Information
